An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum

Post published on the website of the “FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA” (HULAFE) regarding the ProCAncer-I project.

Read more

Source: https://www.iislafe.es/es/investigacion/oficina-internacional/international-research-projects/41/an-ai-platform-integrating-imaging-data-and-models-supporting-precision-care-through-prostate-cancer-s-continuum

Highlights

Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη

Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη

Mar 17, 2021

Ελπίδα για καλύτερη διάγνωση, θεραπεία και βελτιωμένη ποιότητα ζωής στους ασθενείς που πάσχουν από καρκίνο του προστάτη, δίνει το νέο πανευρωπαϊκό πρόγραμμα ProCAncer-I στο οποίο συμμετέχει και η Ελλάδα καθώς συντονιστής φορέας είναι το Ινστιτούτο Τεχνολογίας και Έρευνας (ΙΤΕ) στην Κρήτη.

Fighting prostate cancer with over 1.5 million MRI images

Fighting prostate cancer with over 1.5 million MRI images

Mar 17, 2021

Men die about five years earlier than women across the world. As initiatives to boost awareness of men’s health unfolded in November, an international project is bringing the forefront of AI research to tackle prostate cancer (PC), the second most frequent type of cancer in men and the third most lethal in Europe.

ProCAncer-IFollow

Avatar
AvatarProCAncer-I@ProCAncer_I·
22 Jun

Novartis prostate cancer drug receives U.S. FDA breakthrough designation https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-prostate-cancer-drug-receives-us-fda-breakthrough-designation-2021-06-16/ #prostatecancer

Reply on Twitter 1407349557369970692Retweet on Twitter 14073495573699706922Like on Twitter 14073495573699706927Twitter 1407349557369970692
AvatarProCAncer-I@ProCAncer_I·
15 Jun

Dr Nickolas Papanikolaou is presenting our project ProCAncer-I at the Health IT Conference on Tuesday 15/6/21. He will talk about the creation of a platfrom containing datasets and AI models for monitoring patients with prostate cancer
@FORTH_ITE https://healthdaily.gr/2021/06/12/tin-triti-anoigei-tin-avlaia-tou-to-4o-health-it-conference/

Reply on Twitter 1404762892596092932Retweet on Twitter 14047628925960929321Like on Twitter 14047628925960929324Twitter 1404762892596092932
AvatarProCAncer-I@ProCAncer_I·
27 May

See the first @ProCAncer_I newsletter. Get to know the ProCAncer-I project, its vision, its anonymization strategy, the legal & ethical issues that were dealt & the MRI based AI tools that will improve the management of patients with prostate cancer. https://tinyurl.com/pci-news01

Reply on Twitter 1397925273958457354Retweet on Twitter 13979252739584573548Like on Twitter 13979252739584573547Twitter 1397925273958457354
Retweet on TwitterProCAncer-I Retweeted
AvatarDigital EU 🇪🇺@DigitalEU·
12 May

🤖 #DigitalEU2030
⏰ 1 & 2 June
🖥️ Virtual event

Two days fully dedicated to new #digital technologies, opportunities & next steps to make this Europe's Digital Decade!

Join the debate 👉 http://bit.ly/DigitalEU2030

Reply on Twitter 1392495278540738567Retweet on Twitter 139249527854073856763Like on Twitter 1392495278540738567767Twitter 1392495278540738567
Load More...

Stay in touch!

ProCAncer-I has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 952159http://ec.europa.eu/digital-single-market/ehealth
Conditions of Use | Privacy Policy